API | idecabtagene vicleucel

idecabtagene vicleucel (Abecma) Report issue

Small molecule Orphan Drug ^FDA Approved ^FDA

AACT

Active Ingredient History

NOW

B-cell maturation antigen, also known as tumor necrosis factor receptor superfamily member 17 (TNFRSF17), is a protein that in humans is encoded by the TNFRSF17 gene. ^Wikipedia

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecule:
idecabtagene vicleucel

More Chemistry

Pharmacology

Mechanisms of Action:
- Tumor necrosis factor receptor superfamily member 17 (Homo sapiens) ^UniProt
Multi-specific: Missing data
Black Box: No
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: No

bb2121

Organizations (9)

Research & Development (9)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (1)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (1)

Approved Indications (1)

Multiple Myeloma (approved 2021)

Experimental Indications - Clinical Trial Phases 1-4 (1)

Multiple Myeloma (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 9
# of Trial Organizations: 9

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue